Emily D. Bethea

Projected prevalence and mortality associated with alcohol-related liver disease in the USA, 2019–40: a modelling study

Jovan Julien, Turgay Ayer, Emily D. Bethea et al. · The Lancet Public Health · 2020 · 165 citations · Full text

Tixagevimab/cilgavimab pre-exposure prophylaxis is associated with lower breakthrough infection risk in vaccinated solid organ transplant recipients during the omicron wave

Ayman Al Jurdi, Leela Morená, Mariesa Cote et al. · American Journal of Transplantation · 2022 · 131 citations · Full text

Pre-emptive pangenotypic direct acting antiviral therapy in donor HCV-positive to recipient HCV-negative heart transplantation: an open-label study

Emily D. Bethea, Kerry Gaj, Jenna Gustafson et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 81 citations

Pre-emptive Pangenotypic, Transplantation, Hcv-negative Heart Transplantation +7

Should we treat acute hepatitis C? A decision and cost‐effectiveness analysis

Emily D. Bethea, Qiushi Chen, Chin Hur et al. · Hepatology · 2017 · 70 citations · Full text

A Prospective, Multicenter Study of the AIMS65 Score Compared With the Glasgow-Blatchford Score in Predicting Upper Gastrointestinal Hemorrhage Outcomes

Marwan S. Abougergi, Joseph P. Charpentier, Emily D. Bethea et al. · Journal of Clinical Gastroenterology · 2015 · 62 citations